{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:16:46Z","timestamp":1763968606110,"version":"3.28.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,22]]},"DOI":"10.7759\/cureus.74238","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T15:27:30Z","timestamp":1732289250000},"source":"Crossref","is-referenced-by-count":1,"title":["Rheumatoid Arthritis and Heart Failure: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Korimerla","family":"Deepika","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Lokesh","family":"Moraboina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodipudi","family":"Vineetha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandana Sai","family":"Kodali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hema Sreelakshmi","family":"Guddeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjana","family":"Poladi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandana Priya","family":"Digumurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jashika","family":"Mellamputi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis","volume":"20","author":"Gibofsky A","year":"2014","unstructured":"Gibofsky A. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am J Manag Care. 2014, 20:S128-35.","journal-title":"Am J Manag Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman AJ","year":"2002","unstructured":"Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002, 4:S265-72. 10.1186\/ar578","journal-title":"Arthritis Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-014-1531-1","article-title":"Heart failure: a special issue","volume":"466","author":"van der Velden J","year":"2014","unstructured":"van der Velden J, de Tombe PP. Heart failure: a special issue. Pflugers Arch. 2014, 466:1023. 10.1007\/s00424-014-1531-1","journal-title":"Pflugers Arch"},{"key":"ref4","article-title":"Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis","volume":"18","author":"Gibofsky A","year":"2012","unstructured":"Gibofsky A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care. 2012, 18:S295-302.","journal-title":"Am J Manag Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.11.002","article-title":"Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: the RA-HF study","volume":"85","author":"Ferreira MB","year":"2021","unstructured":"Ferreira MB, Fonseca T, Costa R, et al.. Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: the RA-HF study. Eur J Intern Med. 2021, 85:41-9. 10.1016\/j.ejim.2020.11.002","journal-title":"Eur J Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta JA","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012, 71:1524-9. 10.1136\/annrheumdis-2011-200726","journal-title":"Ann Rheum Dis"},{"key":"ref7","article-title":"Comorbidity in arthritis","volume":"26","author":"Gabriel SE","year":"1999","unstructured":"Gabriel SE, Crowson CS, O'Fallon WM. Comorbidity in arthritis. J Rheumatol. 1999, 26:2475-9.","journal-title":"J Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.21560","article-title":"Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis","volume":"54","author":"Nicola PJ","year":"2006","unstructured":"Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum. 2006, 54:60-7. 10.1002\/art.21560","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/ar2017","article-title":"Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis","volume":"8","author":"Mewar D","year":"2006","unstructured":"Mewar D, Coote A, Moore DJ, et al.. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Arthritis Res Ther. 2006, 8:R128. 10.1186\/ar2017","journal-title":"Arthritis Res Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove J","year":"2012","unstructured":"Sokolove J, Bromberg R, Deane KD, et al.. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One. 2012, 7:e35296. 10.1371\/journal.pone.0035296","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090188","article-title":"Autoantibodies and the risk of cardiovascular events","volume":"36","author":"Liang KP","year":"2009","unstructured":"Liang KP, Kremers HM, Crowson CS, Snyder MR, Therneau TM, Roger VL, Gabriel SE. Autoantibodies and the risk of cardiovascular events. J Rheumatol. 2009, 36:2462-9. 10.3899\/jrheum.090188","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8566-3","article-title":"Cardiac impairment in rheumatoid arthritis and influence of anti-TNF\u03b1 treatment","volume":"52","author":"Laz\u00farov\u00e1 I","year":"2017","unstructured":"Laz\u00farov\u00e1 I, Tom\u00e1\u0161 \u013d. Cardiac impairment in rheumatoid arthritis and influence of anti-TNF\u03b1 treatment. Clin Rev Allergy Immunol. 2017, 52:323-32. 10.1007\/s12016-016-8566-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141647","article-title":"Increased prevalence of diastolic heart failure in patients with rheumatoid arthritis correlates with active disease, but not with treatment type","volume":"42","author":"Schau T","year":"2015","unstructured":"Schau T, Gottwald M, Arbach O, et al.. Increased prevalence of diastolic heart failure in patients with rheumatoid arthritis correlates with active disease, but not with treatment type. J Rheumatol. 2015, 42:2029-37. 10.3899\/jrheum.141647","journal-title":"J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.24390","article-title":"Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis","volume":"61","author":"L\u00f3pez-Longo FJ","year":"2009","unstructured":"L\u00f3pez-Longo FJ, Oliver-Mi\u00f1arro D, de la Torre I, et al.. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum. 2009, 61:419-24. 10.1002\/art.24390","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.06.050","article-title":"Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction","volume":"72","author":"Tromp J","year":"2018","unstructured":"Tromp J, Westenbrink BD, Ouwerkerk W, et al.. Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2018, 72:1081-90. 10.1016\/j.jacc.2018.06.050","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000001004","article-title":"Cardiovascular complications of rheumatoid arthritis","volume":"36","author":"Park E","year":"2024","unstructured":"Park E, Bathon J. Cardiovascular complications of rheumatoid arthritis. Curr Opin Rheumatol. 2024, 36:209-16. 10.1097\/BOR.0000000000001004","journal-title":"Curr Opin Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24804","article-title":"Association between inflammation, incident heart failure, and heart failure subtypes in patients with rheumatoid arthritis","volume":"75","author":"Huang S","year":"2023","unstructured":"Huang S, Cai T, Weber BN, et al.. Association between inflammation, incident heart failure, and heart failure subtypes in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2023, 75:1036-45. 10.1002\/acr.24804","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1377432","article-title":"Rheumatoid arthritis increases the risk of heart failure: results from the cross-sectional study in the US population and mendelian randomization analysis in the European population","volume":"15","author":"Kadier K","year":"2024","unstructured":"Kadier K, Dilixiati D, Zhang X, et al.. Rheumatoid arthritis increases the risk of heart failure: results from the cross-sectional study in the US population and mendelian randomization analysis in the European population. Front Immunol. 2024, 15:1377432. 10.3389\/fimmu.2024.1377432","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02864-0","article-title":"Prospective changes in diastolic function in patients with rheumatoid arthritis","volume":"24","author":"Park E","year":"2022","unstructured":"Park E, Ito K, Iqbal R, et al.. Prospective changes in diastolic function in patients with rheumatoid arthritis. Arthritis Res Ther. 2022, 24:184. 10.1186\/s13075-022-02864-0","journal-title":"Arthritis Res Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.033","article-title":"Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure","volume":"69","author":"Mantel \u00c4","year":"2017","unstructured":"Mantel \u00c4, Holmqvist M, Andersson DC, Lund LH, Askling J. Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure. J Am Coll Cardiol. 2017, 69:1275-85. 10.1016\/j.jacc.2016.12.033","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120941","article-title":"Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis","volume":"40","author":"McCoy SS","year":"2013","unstructured":"McCoy SS, Crowson CS, Maradit-Kremers H, Therneau TM, Roger VL, Matteson EL, Gabriel SE. Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J Rheumatol. 2013, 40:605-10. 10.3899\/jrheum.120941","journal-title":"J Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years","volume":"52","author":"Nicola PJ","year":"2005","unstructured":"Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 2005, 52:412-20. 10.1002\/art.20855","journal-title":"Arthritis Rheum"},{"key":"ref23","article-title":"Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis","volume":"30","author":"Wolfe F","year":"2003","unstructured":"Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003, 30:36-40.","journal-title":"J Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-eular.3746","article-title":"Prevalence of heart failure in rheumatoid arthritis is doubled in remission yet quadrupled in active disease","volume":"73","author":"Schau T","year":"2014","unstructured":"Schau T, Gottwald M, Butter C, Zaenker M. Prevalence of heart failure in rheumatoid arthritis is doubled in remission yet quadrupled in active disease. Ann Rheum Dis. 2014, 73:417-9. 10.1136\/annrheumdis-2014-eular.3746","journal-title":"Ann Rheum Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/art.39267","article-title":"Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study","volume":"67","author":"Mantel \u00c4","year":"2015","unstructured":"Mantel \u00c4, Holmqvist M, Nyberg F, Tornling G, Frisell T, Alfredsson L, Askling J. Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study. Arthritis Rheumatol. 2015, 67:2845-54. 10.1002\/art.39267","journal-title":"Arthritis Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.02.001","article-title":"Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction","volume":"259","author":"Fax\u00e9n J","year":"2023","unstructured":"Fax\u00e9n J, Benson L, Mantel \u00c4, et al.. Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction. Am Heart J. 2023, 259:42-51. 10.1016\/j.ahj.2023.02.001","journal-title":"Am Heart J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2004.09.004","article-title":"TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma","volume":"4","author":"Sarzi-Puttini P","year":"2005","unstructured":"Sarzi-Puttini P, Atzeni F, Shoenfeld Y, Ferraccioli G. TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma. Autoimmun Rev. 2005, 4:153-61. 10.1016\/j.autrev.2004.09.004","journal-title":"Autoimmun Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100979","article-title":"The influence of rheumatoid arthritis disease characteristics on heart failure","volume":"38","author":"Myasoedova E","year":"2011","unstructured":"Myasoedova E, Crowson CS, Nicola PJ, et al.. The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol. 2011, 38:1601-6. 10.3899\/jrheum.100979","journal-title":"J Rheumatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem033","article-title":"A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases","volume":"46","author":"Weisman MH","year":"2007","unstructured":"Weisman MH, Paulus HE, Burch FX, et al.. A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases. Rheumatology (Oxford). 2007, 46:1122-5. 10.1093\/rheumatology\/kem033","journal-title":"Rheumatology (Oxford)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17938","article-title":"Cardiovascular risk associated with TNF alpha inhibitor use in patients with rheumatoid arthritis","volume":"13","author":"Hussain A","year":"2021","unstructured":"Hussain A, Tarahomi T, Singh L, Bollampally M, Heydari-Kamjani M, Kesselman MM. Cardiovascular risk associated with TNF alpha inhibitor use in patients with rheumatoid arthritis. Cureus. 2021, 13:e17938. 10.7759\/cureus.17938","journal-title":"Cureus"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca R","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, et al.. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017, 76:17-28. 10.1136\/annrheumdis-2016-209775","journal-title":"Ann Rheum Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/art.41095","article-title":"Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial","volume":"72","author":"Giles JT","year":"2020","unstructured":"Giles JT, Sattar N, Gabriel S, et al.. Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial. Arthritis Rheumatol. 2020, 72:31-40. 10.1002\/art.41095","journal-title":"Arthritis Rheumatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon WG","year":"2007","unstructured":"Dixon WG, Watson KD, Lunt M, Hyrich KL, Silman AJ, Symmons DP. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2007, 56:2905-12. 10.1002\/art.22809","journal-title":"Arthritis Rheum"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/art.39582","article-title":"Association between ischemic stroke and tumor necrosis factor inhibitor therapy in patients with rheumatoid arthritis","volume":"68","author":"Low AS","year":"2016","unstructured":"Low AS, Lunt M, Mercer LK, Watson KD, Dixon WG, Symmons DP, Hyrich KL. Association between ischemic stroke and tumor necrosis factor inhibitor therapy in patients with rheumatoid arthritis. Arthritis Rheumatol. 2016, 68:1337-45. 10.1002\/art.39582","journal-title":"Arthritis Rheumatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7712587","article-title":"The biological disease-modifying antirheumatic drugs and the risk of cardiovascular events: a systematic review and meta-analysis","volume":"2021","author":"Hu S","year":"2021","unstructured":"Hu S, Lin C, Cai X, Zhu X, Lv F, Nie L, Ji L. The biological disease-modifying antirheumatic drugs and the risk of cardiovascular events: a systematic review and meta-analysis. Mediators Inflamm. 2021, 2021:7712587. 10.1155\/2021\/7712587","journal-title":"Mediators Inflamm"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003912","article-title":"Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b\/4 randomised safety study","volume":"10","author":"Buch MH","year":"2024","unstructured":"Buch MH, Bhatt DL, Charles-Schoeman C, et al.. Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b\/4 randomised safety study. RMD Open. 2024, 10:26-8. 10.1136\/rmdopen-2023-003912","journal-title":"RMD Open"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2174\/0929867322666150209160701","article-title":"Tumor necrosis factor blocking therapy and congestive heart failure in patients with inflammatory rheumatic disorders: a systematic review","volume":"22","author":"Heslinga SC","year":"2015","unstructured":"Heslinga SC, Van Sijl AM, De Boer K, Van Halm VP, Nurmohamed MT. Tumor necrosis factor blocking therapy and congestive heart failure in patients with inflammatory rheumatic disorders: a systematic review. Curr Med Chem. 2015, 22:1892-902. 10.2174\/0929867322666150209160701","journal-title":"Curr Med Chem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306724-rheumatoid-arthritis-and-heart-failure-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T15:27:33Z","timestamp":1732289253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306724-rheumatoid-arthritis-and-heart-failure-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.74238","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,22]]}}}